Charles R. Kummeth
Net Worth

Last updated:

What is Charles R. Kummeth net worth?

The estimated net worth of Mr. Charles R. Kummeth is at least $128,777,265 as of 15 Aug 2023. He owns shares worth $68,980,377 as insider, has earned $22,276,888 from insider trading and has received compensation worth at least $37,520,000 in Bio-Techne Corporation.

What is the salary of Charles R. Kummeth?

Mr. Charles R. Kummeth salary is $4,690,000 per year as Chief Executive Officer, Pres & Director in Bio-Techne Corporation.

How old is Charles R. Kummeth?

Mr. Charles R. Kummeth is 65 years old, born in 1960.

What stocks does Charles R. Kummeth currently own?

As insider, Mr. Charles R. Kummeth owns shares in one company:

Company Title Shares Price per share Total value
Bio-Techne Corporation (TECH) Chief Executive Officer, Pres & Director 1,258,766 $54.8 $68,980,377

What does Bio-Techne Corporation do?

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Charles R. Kummeth insider trading

Bio-Techne Corporation

Mr. Charles R. Kummeth has made 22 insider trades between 2017-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 616,676 units of TECH stock on 30 Jun 2023. As of 15 Aug 2023 he still owns at least 1,258,766 units of TECH stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 17,632 N/A N/A
Option
Common Stock 51,516 N/A N/A
Option
Restricted Stock Units 51,516 N/A N/A
Sale
Common Stock 80,000 $88.36 $7,069,040
Option
Common Stock 616,676 $26.65 $16,434,415
Option
Stock Options (Right to Buy) 616,676 $26.65 $16,434,415
Sale
Common Stock 322 $83 $26,726
Option
Common Stock 407,364 $26.65 $10,856,251
Option
Stock Options (Right to Buy) 407,364 N/A N/A
Option
Restricted Stock Units 16,937 N/A N/A
Option
Common Stock 16,918 N/A N/A
Option
Stock Option (right to buy) 45,346 $108.49 $4,919,588
Option
Common Stock 45,346 $108.49 $4,919,588
Option
Common Stock 50,000 $108.49 $5,424,500
Option
Stock Option (right to buy) 50,000 $108.49 $5,424,500
Sale
Common Stock 5,104 $365 $1,862,960
Option
Stock Option (right to buy) 5,104 $108.49 $553,733
Option
Common Stock 5,104 $108.49 $553,733
Option
Stock Options (Right to Buy) 1,737 $115.82 $201,179
Option
Common Stock 1,737 $115.82 $201,179
Option
Stock Options (Right to Buy) 73,492 $108.49 $7,973,147
Option
Common Stock 73,492 $108.49 $7,973,147
Option
Stock Options (Right to Buy) 921 $108.49 $99,919
Option
Common Stock 921 $108.49 $99,919
Option
Common Stock 16,918 $108.49 $1,835,434
Option
Restricted Stock Units 16,918 $108.49 $1,835,434
Sale
Common Stock 2,909 $449.73 $1,308,265
Sale
Common Stock 9,589 $450.85 $4,323,220
Sale
Common Stock 9,589 $450.85 $4,323,220
Sale
Common Stock 7,481 $449.6 $3,363,458
Option
Common Stock 36,849 $94.35 $3,476,703
Option
Stock Options (Right to Buy) 36,849 $94.35 $3,476,703
Option
Common Stock 30,000 N/A N/A
Option
Stock Options (Right to Buy) 30,000 N/A N/A
Sale
Common Stock 20,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Option
Stock Options (Right to Buy) 25,157 N/A N/A
Option
Common Stock 25,157 N/A N/A
Option
Common Stock 21,291 N/A N/A
Option
Restricted Stock Units 21,291 N/A N/A
Option
Common Stock 21,159 N/A N/A
Option
Stock Options (Right to Buy) 21,159 N/A N/A
Option
Common Stock 10,276 N/A N/A
Sale
Common Stock 10,276 N/A N/A
Option
Stock Options (Right to Buy) 10,276 N/A N/A
Option
Stock Options (Right to Buy) 7,999 N/A N/A
Option
Common Stock 7,999 N/A N/A
Sale
Common Stock 7,999 N/A N/A
Option
Stock Options (Right to Buy) 19,843 N/A N/A
Option
Common Stock 19,843 N/A N/A
Sale
Common Stock 19,843 N/A N/A
Option
Common Stock 471 N/A N/A
Sale
Common Stock 471 N/A N/A
Option
Stock Options (Right to Buy) 471 N/A N/A
Option
Common Stock 659 N/A N/A
Option
Stock Options (Right to Buy) 659 N/A N/A
Sale
Common Stock 659 N/A N/A
Option
Stock Options (Right to Buy) 5,767 N/A N/A
Option
Common Stock 5,767 N/A N/A
Sale
Common Stock 5,767 N/A N/A
Option
Common Stock 703 N/A N/A
Option
Stock Options (Right to Buy) 703 N/A N/A
Sale
Common Stock 703 N/A N/A
Sale
Common Stock 100 N/A N/A
Option
Common Stock 11,772 N/A N/A
Sale
Common Stock 11,772 N/A N/A
Option
Stock Options (Right to Buy) 11,772 N/A N/A
Purchase
Common Stock 100 N/A N/A
Option
Restricted Stock Units 24,979 N/A N/A
Option
Common Stock 24,979 N/A N/A
Option
Stock Options (Right to Buy) 7,410 N/A N/A
Option
Common Stock 7,410 N/A N/A
Option
Stock Options (Right to buy) 16,969 N/A N/A
Option
Common Stock 16,969 N/A N/A
Sale
Common Stock 16,969 N/A N/A
Sale
Common Stock 15,037 N/A N/A
Option
Stock Options (Right to buy) 15,037 N/A N/A
Option
Common Stock 15,037 N/A N/A
Option
Stock Options (Right to buy) 17,994 N/A N/A
Sale
Common Stock 17,994 N/A N/A
Option
Common Stock 17,994 N/A N/A
Option
Restricted Stock Units 13,816 N/A N/A
Option
Common Stock 13,816 N/A N/A
Sale
Common Stock 8,000 N/A N/A
Option
Common Stock 9,248 N/A N/A

Bio-Techne key executives

Bio-Techne Corporation executives and other stock owners filed with the SEC: